Exxel Pharma's Innovative Small Molecule, EX937, Rapidly Advancing Toward First-In-Human Study for the Treatment of Refractory Chronic Cough
EX937 utilizes a differentiated approach by inhibiting the FAAH enzyme, which increases the levels of Anandamide, an ...